| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/12/2007 | US20070160629 Purified active HCV NS2/3 protease |
| 07/12/2007 | US20070160628 Stabilized virus-like particles and epitope display systems |
| 07/12/2007 | US20070160627 wherein IL1 beta R coding sequence has been inactivated for use in immunotherapy and vaccination, wherein MVA mutant comprises DNA sequences coding for a heterologous protein derived from therapeutic polypeptides and polypeptides of pathogenic agents, wherein MVA mutant leads to enhanced memory response |
| 07/12/2007 | US20070160624 Peptides of the Bacillus anthracis Anthrax Toxin Lethal factor Protein pX01-107; methods of stimulating immune response; antisense agents; vaccine |
| 07/12/2007 | US20070160623 Innate immune system-directed vaccines |
| 07/12/2007 | US20070160622 Method for assembling a polymer-biologic delivery composition |
| 07/12/2007 | US20070160621 Heat shock proteins from Mycobacterium Leprae and uses thereof |
| 07/12/2007 | US20070160620 Immune responses using compositions containing stress proteins |
| 07/12/2007 | US20070160619 CTLA-4 Antibody Dosage Escalation Regimens |
| 07/12/2007 | US20070160618 Cardiotrophin-1 compositions and methods for the treatment of tumor |
| 07/12/2007 | US20070160617 PSMA antibody-drug conjugates |
| 07/12/2007 | US20070160616 Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereof |
| 07/12/2007 | US20070160615 Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of Alzheimer's disease |
| 07/12/2007 | US20070160614 Human TIMP-1 antibodies |
| 07/12/2007 | US20070160613 Monoclonal antibodies to hepatocyte growth factor |
| 07/12/2007 | US20070160612 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 07/12/2007 | US20070160611 Administering a mammal an IL-31RA or OSMRb (Oncostatin M receptor beta) antagonist, wherein such antagonist is an antibody or soluble receptor to treat the inflammation by reducing, limiting, minimizing or neutralizing stimulation in neuronal tissues |
| 07/12/2007 | US20070160610 Methods of treating pain and inflammation in neuronal tissue using il-31 antagonists |
| 07/12/2007 | US20070160609 Interferon antagonists useful for the treatment of interferon related diseases |
| 07/12/2007 | US20070160608 Treatment with anti-vegf antibodies |
| 07/12/2007 | US20070160607 Humanized monoclonal antibodies that protect against shiga toxin induced disease |
| 07/12/2007 | US20070160606 Treating renal cell carcinoma with an anti-TNF human antibody or fragment |
| 07/12/2007 | US20070160605 Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody |
| 07/12/2007 | US20070160604 Methods of identifying compounds capable of modulating t cell immune responses involving sema4a protein |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160602 Compositions and methods of using galectin-8 as an inhibitor of tumor cell growth |
| 07/12/2007 | US20070160601 Neutralizing antibodies against primate psgl-1 and uses therefor |
| 07/12/2007 | US20070160600 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 07/12/2007 | US20070160599 Thimerosal removal device |
| 07/12/2007 | US20070160598 Binding polypeptides with diversified and consensus vh/vl hypervariable sequences |
| 07/12/2007 | US20070160597 Optimized Fc variants and methods for their generation |
| 07/12/2007 | US20070160596 For use as suppressors of cancer, cell or tissue proliferation and of inflammatory disorders |
| 07/12/2007 | US20070160595 Human Tumor Necrosis Factor TR20 and Methods Based Thereon |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160587 Allogeneic tumor therapeutic agent, a vaccine using allogeneic tumor cells for the therapeutic treatment of tumor diseases, and a method for the making of such a vaccine, and transfected human tumor cells for use as a vaccine |
| 07/12/2007 | US20070160585 Remedy for prion disease and method of producing the same |
| 07/12/2007 | US20070160579 Methods of modulating a mammalian cytokine |
| 07/12/2007 | US20070160578 Expansion of natural killer and CD8 T-cells with IL-15R/ligand activator complexes |
| 07/12/2007 | US20070160577 Interleukin-11 compositions and methods of use |
| 07/12/2007 | US20070160574 Design of CXC chemokine analogs for the treatment of human diseases |
| 07/12/2007 | US20070160572 Colloidal metal compositions and methods |
| 07/12/2007 | US20070160571 Composition and method for inducing protective vaccine response |
| 07/12/2007 | US20070160570 Chimeric polypeptides containing chemokine domains |
| 07/12/2007 | US20070160539 HPRP4s Modifiers of the p53 Pathway and Methods of Use |
| 07/12/2007 | US20070160534 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 07/12/2007 | US20070160530 Antibodies and molecules derived therefrom that bind to steap-1 proteins |
| 07/12/2007 | US20070160528 Method to evaluate the likelehood of development of bone metastasis based on the determination of calcium binding proteins |
| 07/12/2007 | DE112005001901T5 Einfangen und entfernen von Biomolekülen aus Körperflüssigkeiten unter Verwendung von partiellen molekularen Abdrücken Remove and capture of biomolecules from body fluids using partial molecular imprints |
| 07/12/2007 | CA2674269A1 Three component carbohydrate vaccine |
| 07/12/2007 | CA2671322A1 Compositions and methods for treating actin-mediated medical conditions by administering an actin modulating agent |
| 07/12/2007 | CA2638005A1 A therapeutic composition comprising an inhibitor of an hsp 90 protein |
| 07/12/2007 | CA2636265A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 07/12/2007 | CA2636257A1 Immune adjuvant |
| 07/12/2007 | CA2636074A1 Combination therapy using anti-egfr and anti-her2 antibodies |
| 07/12/2007 | CA2635992A1 Medicament for topical use |
| 07/12/2007 | CA2635889A1 Drug-polymer conjugates |
| 07/12/2007 | CA2635849A1 An antibody against periosin, and a pharmaceutical composition comprising it for preventing or treating a disease in which periosin is involved |
| 07/12/2007 | CA2635623A1 Anti-cd19 antibodies with reduced immunogenicity |
| 07/12/2007 | CA2635615A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130 |
| 07/12/2007 | CA2635588A1 Metalloproteinase binding proteins |
| 07/12/2007 | CA2635560A1 Chicken virus vaccine and diagnostic |
| 07/12/2007 | CA2634997A1 Immunoglobulin g (igg) concentrate depleted of anti-a and anti-b antibodies and of polyreactive iggs |
| 07/12/2007 | CA2633222A1 Antibodies directed to her-3 and uses thereof |
| 07/12/2007 | CA2631108A1 Combination comprising combretastatin and anticancer agents |
| 07/11/2007 | EP1806404A1 Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/11/2007 | EP1806403A2 Human cancer antigen NY ESO 1/CAG-3 and gene encoding same |
| 07/11/2007 | EP1806402A2 CTLA4/CD28 ligands and uses therefor |
| 07/11/2007 | EP1806395A1 Maturation of dendritic cells |
| 07/11/2007 | EP1806364A2 New anti-IGF-IR antibodies and their applications |
| 07/11/2007 | EP1806359A1 Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 07/11/2007 | EP1806358A2 Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| 07/11/2007 | EP1806147A1 Use of immunesuppressant receptor |
| 07/11/2007 | EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines |
| 07/11/2007 | EP1806145A1 Remedy for inflammatory diseases |
| 07/11/2007 | EP1806144A2 Use of SARP-1 for the treatment and/or prevention of scleroderma |
| 07/11/2007 | EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent |
| 07/11/2007 | EP1806142A1 Method for the production of (poly)peptides by using truncated variants of the SV 40 large T antigen with an intact N terminus |
| 07/11/2007 | EP1806139A2 Immune stimulation using chemically modified RNA |
| 07/11/2007 | EP1805515A2 Immunoassays for lamotrigine |
| 07/11/2007 | EP1805510A1 Therapeutic strategy for treating autoimmune and degenerative diseases |
| 07/11/2007 | EP1805222A1 Antibodies directed to the mammalian eag1 ion channel protein |
| 07/11/2007 | EP1805221A1 Monoclonal antibody against frizzled receptors |
| 07/11/2007 | EP1805219A1 Angiopoietin-2 specific binding agents |
| 07/11/2007 | EP1805214A2 T-cell stimulatory peptides from the melanoma-associated chondroitin sulfate proteoglycan and their use |
| 07/11/2007 | EP1805198A2 Interleukin-9 and interleukin-4 chimeric antagonist muteins and methods of using same |
| 07/11/2007 | EP1804836A2 Methods of diagnosing and treating complications of pregnancy |
| 07/11/2007 | EP1804835A2 Multimeric constructs |
| 07/11/2007 | EP1804834A2 Immunogenic bacterial vesicles with outer membrane proteins |
| 07/11/2007 | EP1804833A2 Staphylococcal immunogenic compositions |
| 07/11/2007 | EP1804831A2 Listeria-based and llo-based vaccines |
| 07/11/2007 | EP1804830A2 Cancer-testis antigens |
| 07/11/2007 | EP1804829A1 T-cadherin antigen arrays and uses thereof |
| 07/11/2007 | EP1804822A1 Hcv vaccines for chronic hcv patients |
| 07/11/2007 | EP1804583A2 Adjuvant for dna vaccines |
| 07/11/2007 | EP1639029B1 Biodegradable poly(beta-amino esters) and uses thereof |
| 07/11/2007 | EP1553832B1 Cell separation compositions and methods |
| 07/11/2007 | EP1420822B1 Modified vaccinia virus ankara for the vaccination of neonates |
| 07/11/2007 | EP1395829B1 Cancer associated protein |
| 07/11/2007 | EP1370666B1 Genetic immunisation against cervical carcinoma |
| 07/11/2007 | EP1242108B1 Optimized minigenes and peptides encoded thereby |